GENSIA

Gensia Biologics, Inc

Application Filed: 2022-08-17

Trademark Application Details

Mark For: GENSIA™ trademark registration is intended to cover the categories of biological preparations for the treatment of Cancer, Anemia, Rheumatoid arthritis (RA), Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Psoriasis, Diabetes, Multiple sclerosis (MS), Heart attack, Systemic lupus erythematous, Age-related macular degeneration, Diabetes, Diabetic retinopathy, Prevention of pneumonia, Anemia, Chronic migraine, Hepatitis B, Hemophilia, Respiratory syncytial virus (RSV) prophylaxis, HPV prevention, Varicella virus vaccine, Growth hormone deficiency, Botox, Osteoporosis, Allergic asthma, Chronic idiopathic urticaria, Infertility, Prevention of meningococcal disease, Cystic fibrosis, Paroxysmal nocturnal hemoglobinuria, and recombinant biological agents.

Status

2022-08-20 UTC

LIVE APPLICATION Awaiting Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Website	www.gensiabio.com
Research	OneLook Acronym Finder
Serial Number	97553238
Mark Literal Elements	GENSIA
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	Trademark
Current Location	NEW APPLICATION PROCESSING 2022-08-20
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No

Timeline

2022-08-17	Application Filed
2022-08-20	Location: NEW APPLICATION PROCESSING
2022-08-20	Status: Live/Pending
2022-08-20	Status: New application will be assigned to an examining attorney approximately 6 months after filing date.
2022-08-20	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Gensia Biologics, Inc
Address	20 Riverside Drive Deerfield, ILLINOIS UNITED STATES 60015
Legal Entity Type	Limited Liability Company
Legal Entity State	ILLINOIS

Documents

Drawing		2022-08-17
TEAS Plus New Application		2022-08-17

Attorney of Record

GENSIA BIOLOGICS, INC
20 RIVERSIDE DRIVE
DEERFIELD, IL 60015

Good, Services, and Codes

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
GS0051	Biological preparations for the treatment of Cancer, Anemia, Rheumatoid arthritis (RA), Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Psoriasis, Diabetes, Multiple sclerosis (MS), Heart attack, Systemic lupus erythematous, Age-related macular degeneration, Diabetes, Diabetic retinopathy, Prevention of pneumonia, Anemia, Chronic migraine, Hepatitis B, Hemophilia, Respiratory syncytial virus (RSV) prophylaxis, HPV prevention, Varicella virus vaccine, Growth hormone deficiency, Botox, Osteoporosis, Allergic asthma, Chronic idiopathic urticaria, Infertility, Prevention of meningococcal disease, Cystic fibrosis, Paroxysmal nocturnal hemoglobinuria, and recombinant biological agents

Type Code

Type

GS0051

Biological preparations for the treatment of Cancer, Anemia, Rheumatoid arthritis (RA), Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Psoriasis, Diabetes, Multiple sclerosis (MS), Heart attack, Systemic lupus erythematous, Age-related macular degeneration, Diabetes, Diabetic retinopathy, Prevention of pneumonia, Anemia, Chronic migraine, Hepatitis B, Hemophilia, Respiratory syncytial virus (RSV) prophylaxis, HPV prevention, Varicella virus vaccine, Growth hormone deficiency, Botox, Osteoporosis, Allergic asthma, Chronic idiopathic urticaria, Infertility, Prevention of meningococcal disease, Cystic fibrosis, Paroxysmal nocturnal hemoglobinuria, and recombinant biological agents

Trademark Filing History

Description	Date	Proceeding Number
NEW APPLICATION ENTERED IN TRAM	2022-08-20

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
GENSIA 97553238 not registered Live/Pending	Gensia Biologics, Inc 2022-08-17
GENSIA 74257697 1758801 Dead/Cancelled	SICOR, INC. 1992-03-23
GENSIA 73811171 1656481 Dead/Cancelled	GENSIA EUROPE LIMITED 1989-07-06
GENSIA 73811170 1648630 Dead/Cancelled	GENSIA EUROPE LIMITED 1989-07-06
GENSIA 73811169 1707944 Dead/Cancelled	GENSIA EUROPE LIMITED 1989-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.